Schrödinger, Inc. (SDGR) Stock

Healthcare · Health Information Services · Member of Other US Stocks

Schrödinger, Inc. (SDGR) closed at USD 25.05 on 2026-10-14, a change of +15.1 % over the past year, with a market capitalization of USD 1.91B.

Schrödinger, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Schrödinger, Inc. key figures

Previous close

USD 25.05 (2026-10-14)

1-year change

+15.1 %

Market cap

USD 1.91B

Enterprise value

USD 1.6B

P/E ratio (trailing)

-34.43

P/E ratio (forward)

-18.87

EPS (trailing)

-0.74

EPS (forward)

-1.35

PEG ratio

n/a

Price to book

5.64

Revenue growth

7.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.41

Employees

850

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Schrödinger, Inc. and compare it with other stocks.